Mersana Therapeutics, Inc. — Director's Dealing 2017

Jun 28, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Mersana Therapeutics, Inc. (MRSN)
CIK: 0001442836
Period of Report: 2017-06-27

Reporting Person: Hege Kristen (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to Purchase Common Stock	$4.10	2026-08-29	Common Stock (52222)		Direct

Footnotes

F1: The options vest 25% on August 15, 2017 and in equal quarterly installments thereafter.